全文获取类型
收费全文 | 9217篇 |
免费 | 470篇 |
国内免费 | 40篇 |
专业分类
耳鼻咽喉 | 73篇 |
儿科学 | 156篇 |
妇产科学 | 124篇 |
基础医学 | 1249篇 |
口腔科学 | 983篇 |
临床医学 | 808篇 |
内科学 | 1892篇 |
皮肤病学 | 226篇 |
神经病学 | 807篇 |
特种医学 | 288篇 |
外科学 | 1306篇 |
综合类 | 31篇 |
一般理论 | 1篇 |
预防医学 | 609篇 |
眼科学 | 219篇 |
药学 | 587篇 |
中国医学 | 54篇 |
肿瘤学 | 314篇 |
出版年
2023年 | 66篇 |
2022年 | 59篇 |
2021年 | 266篇 |
2020年 | 201篇 |
2019年 | 244篇 |
2018年 | 322篇 |
2017年 | 204篇 |
2016年 | 223篇 |
2015年 | 322篇 |
2014年 | 431篇 |
2013年 | 483篇 |
2012年 | 826篇 |
2011年 | 896篇 |
2010年 | 522篇 |
2009年 | 406篇 |
2008年 | 657篇 |
2007年 | 693篇 |
2006年 | 648篇 |
2005年 | 530篇 |
2004年 | 489篇 |
2003年 | 393篇 |
2002年 | 341篇 |
2001年 | 50篇 |
2000年 | 45篇 |
1999年 | 56篇 |
1998年 | 32篇 |
1997年 | 32篇 |
1996年 | 25篇 |
1995年 | 17篇 |
1994年 | 22篇 |
1993年 | 20篇 |
1992年 | 20篇 |
1991年 | 23篇 |
1990年 | 11篇 |
1989年 | 22篇 |
1988年 | 10篇 |
1987年 | 13篇 |
1986年 | 15篇 |
1985年 | 10篇 |
1984年 | 16篇 |
1983年 | 3篇 |
1982年 | 7篇 |
1981年 | 8篇 |
1980年 | 6篇 |
1979年 | 6篇 |
1978年 | 3篇 |
1976年 | 4篇 |
1968年 | 5篇 |
1965年 | 3篇 |
1964年 | 2篇 |
排序方式: 共有9727条查询结果,搜索用时 15 毫秒
1.
Danielle Mann MD MSc Flavia M. Sant’Anna MD MSc Carolina A. S. Schmaltz MD PhD Valeria Rolla MD PhD Dayvison F. S. Freitas MD PhD Marcelo R. Lyra MD PhD Felipe M. S. Sampaio MD MSc Antonio C. F. do Valle MD PhD Maria C. S Lourenço MSc Leonardo P. Quintella MD PhD Tullia C. Teichner MD PhD Solange C. Cavalcante MD PhD Maria C. G. Galhardo MD PhD 《International journal of dermatology》2019,58(12):1451-1459
2.
3.
4.
Luiza Ferracini Cunha Mariana Aubin Ongaratto Marcelo Endres Alethea Gatto Barschak 《International journal of experimental pathology》2021,102(2):74
Hypercholesterolaemia is a complex condition with multiple causes, including both lifestyle and genetic aspects. It is also a risk factor for cardiovascular diseases (CVDs), which are responsible for 172 million deaths/year. Although the reasons for hypercholesterolaemia are known, there are many critical questions that remain to be answered so that new therapeutics can be developed. In order to elucidate the pathobiology of this condition, animal models can mimic the pathology of human hypercholesterolaemia. One example of an animal model is induced by the hypercholesterolaemic diet in Wistar rats. The present review first summarizes the current understanding of the metabolic profile involved in hypercholesterolaemia in humans. Next it comments about the lack of consensus as to which hypercholesterolaemia induction protocol should be used. The present work aimed to review experimental studies that induced hypercholesterolaemia in Wistar rats it was not intended to judge the “best” model, since they all achieved the goal of inducing an increase in serum cholesterol. 相似文献
5.
Nancy Vargas-Mendoza Jazm n Garc a-Machorro Marcelo Angeles-Valencia Marlet Mart nez-Archundia Eduardo Osiris Madrigal-Santill n ngel Morales-Gonz lez Liliana Anguiano-Robledo Jos A Morales-Gonz lez 《World journal of gastroenterology : WJG》2021,27(34):5630-5665
Coronavirus disease 2019 (COVID-19), which is caused by severe acute respi ratory syndrome-coronavirus-2 (SARS-CoV-2), has affected millions of people globally. It was declared a pandemic by the World Health Organization in March 2020. The hyperinflammatory response to the entry of SARS-CoV-2 into the host through angiotensin-converting enzyme 2 is the result of a “cytokine storm” and the high oxidative stress responsible for the associated symptomatology. Not only respiratory symptoms are reported, but gastrointestinal symptoms (diarrhea, vomiting, and nausea) and liver abnormalities (high levels of aspartate amino transferase, alanine aminotransferase transaminases, and bilirubin) are observed in at least 30% of patients. Reduced food intake and a delay in medical services may lead to malnutrition, which increases mortality and poor outcomes. This review provides some strategies to identify malnutrition and establishes nutri tional approaches for the management of COVID-19 and liver injury, taking energy and nutrient requirements and their impact on the immune response into account. The roles of certain phytochemicals in the prevention of the disease or as promising target drugs in the treatment of this disease are also considered. 相似文献
6.
Marcelo Sato‐Sano Solange Pistori Teixeira Juliano Cordova Vargas Otvio Cesar Carvalho Guimares Baiocchi Milvia Maria Simes e Silva Enokihara Elimar Elias Gomes Mariana Dias Batista 《The Journal of dermatology》2019,46(7):618-621
Eosinophilic dermatosis of hematological malignancy is a paraneoplastic skin eruption associated with chronic lymphocytic leukemia and other B‐cell malignancies. It clinically resembles an insect bite reaction and it can precede the symptoms of the hematological malignancy or be related to a more aggressive course. Different treatments have been proposed, but partial response and recurrence are frequent. Herein, we describe a case of eosinophilic dermatosis associated with mantle cell lymphoma with remission after lenalidomide therapy. 相似文献
7.
Edson Donizetti Verri Gabriel Pdua da Silva Evandro Marianetti Fioco Nayara Soares da Silva Saulo Csar Valin Fabrin Cesar Augusto Bueno Zanella Camila Roberta Garrefa Milton Faria Júnior Selma Sissere Jaime Eduardo Cecilio Hallak Marcelo Palinkas Thais Cristina Chaves Simone Cecilio Hallak Regalo 《Journal of oral rehabilitation》2019,46(10):912-919
8.
Marcelo Pillonetto Alana Mazzetti Guilherme N. Becker Christian A. Siebra Lavinia N.V.S Arend Afonso L. Barth 《Diagnostic microbiology and infectious disease》2019,93(2):140-142
We report 26 human isolates of mcr-1–positive Escherichia coli, most of them (65.4%) with a polymyxin B MIC of 2?mg/L. Seventeen out of the 24 mcr-1–positive E. coli proved to be nonclonal by rep-PCR which strengthens the hypothesis of environmental or animal origin of these strains and reinforces the one health context of antimicrobial resistance. 相似文献
9.
Américo Danúzio Pereira de Oliveira Luciana Patrizia Alves de Andrade-Valença Marcelo Moraes Valença 《Journal of stroke and cerebrovascular diseases》2019,28(10):104281
IntroductionThe highest mortality rates associated with ischemic stroke occur in patients of advanced age. However, studies of factors that establish the increase in hospital mortality are scanty in this population.Material and MethodsEpidemiologic, clinical and laboratory data, etiology and ischemic stroke subtype and complications during hospitalization were analyzed in 195 patients aged 80 years or older. In attempt to associate prognostic factor with the in-hospital mortality during first 28 days from admission, the death and survivor groups were compared.ResultsAmong the 195 patients evaluated, the age was 85.3 ± 4.6 years with a mortality of 26.1%. Following the multivariate model, the factors associated with in-hospital mortality were: age (OR = 1.07, 95% CI = 1.00-1.20), the score less than or equal to 8 on Glasgow coma scale (OR = 22.87, 95% CI = 3.55-148.76), diabetes mellitus (OR = 3.40, 95% CI = 1.30-8.87), total anterior clinical subtype (OR = 5.15, 95% CI = 1.82-14.52) and infectious complications (OR = 8.38, 95% CI = 3.28-21.43).ConclusionsThe following risk factors were associated with a higher in-hospital mortality rate in patients over 79 years of age with ischemic stroke: older age, Glasgow coma score less than or equal to 8, total anterior circulation infarction, infection, and diabetes mellitus. 相似文献
10.